Open Access

TRIM21‑a potential biomarker for the prognosis of thyroid cancer

  • Authors:
    • Zhen Wu
    • Yongkun Wang
    • Zhengya Yu
    • Zhen Meng
    • Wenchao Duan
    • Wei Zhang
    • Jugao Fang
  • View Affiliations

  • Published online on: November 9, 2022     https://doi.org/10.3892/etm.2022.11697
  • Article Number: 761
  • Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Thyroid cancer (THCA) is one of the commonest malignancies associated with increased recurrence. Therefore, identifying the putative molecular markers and therapeutic targets to improve the treatment of THCA is essential. The present study analyzed the potential role of tripartite motif‑containing 21 (TRIM21), a member of the TRIM family belonging to the subfamily of E3 ubiquitin ligases, in the progression of THCA. Using bioinformatics analysis and immunohistochemistry of THCA tissues, it was observed that TRIM21 is overexpressed in THCA tissues. The present study also found that TRIM21 is associated with lymph node metastasis and high‑risk recurrence of THCA. Furthermore, it identified a promotional role of TRIM21 in THCA cell migration and invasion. In addition, the present study analyzed TRIM21‑enriched pathways and co‑expressed genes in THCA. The present study suggested that TRIM21 may serve as a potential biomarker for THCA prognosis.

Related Articles

Journal Cover

December-2022
Volume 24 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wu Z, Wang Y, Yu Z, Meng Z, Duan W, Zhang W and Fang J: TRIM21‑a potential biomarker for the prognosis of thyroid cancer. Exp Ther Med 24: 761, 2022
APA
Wu, Z., Wang, Y., Yu, Z., Meng, Z., Duan, W., Zhang, W., & Fang, J. (2022). TRIM21‑a potential biomarker for the prognosis of thyroid cancer. Experimental and Therapeutic Medicine, 24, 761. https://doi.org/10.3892/etm.2022.11697
MLA
Wu, Z., Wang, Y., Yu, Z., Meng, Z., Duan, W., Zhang, W., Fang, J."TRIM21‑a potential biomarker for the prognosis of thyroid cancer". Experimental and Therapeutic Medicine 24.6 (2022): 761.
Chicago
Wu, Z., Wang, Y., Yu, Z., Meng, Z., Duan, W., Zhang, W., Fang, J."TRIM21‑a potential biomarker for the prognosis of thyroid cancer". Experimental and Therapeutic Medicine 24, no. 6 (2022): 761. https://doi.org/10.3892/etm.2022.11697